PCVX - Vaxcyte, Inc.
NEXT EARNINGS:
May 11, 2026
EPS Est: $-1.52
|
Rev Est: $9.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$77.00
DETAILS
HIGH:
$77.00
LOW:
$77.00
MEDIAN:
$77.00
CONSENSUS:
$77.00
UPSIDE:
25.51%
Market Cap:
8.71B
Volume:
811,272
Avg Volume:
1,399,561
52 Week Range:
27.66-83.33
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.34
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
414
IPO Date:
2020-06-12
EPS (TTM):
-3.80
P/E Ratio:
-8.19
Revenue (TTM):
N/A
Total Assets:
3.51B
Total Debt:
71.11M
Cash & Equiv:
387.88M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-13.8%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-1.81 | $-1.46 | -24.0% | — | — | — |
| 2025-11-04 | $-1.56 | $-1.27 | -22.8% | — | — | — |
| 2025-08-06 | $-1.22 | $-1.12 | -8.9% | — | — | — |
| 2025-05-07 | $-1.04 | $-1.02 | -2.0% | — | — | — |
| 2025-02-25 | $-1.02 | $-1.16 | +12.1% | — | — | — |
| 2024-11-05 | $-0.83 | $-1.10 | +24.5% | — | — | — |
| 2024-08-06 | $-1.10 | $-0.98 | -12.8% | — | — | — |
| 2024-05-08 | $-0.85 | $-1.13 | +24.8% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (463.93M) | (402.27M) | (223.49M) | (100.08M) | (89.22M) | (50.27M) | (29.48M) | (17.24M) |
| EPS | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.84 |
| Total Assets | 3.51B | 1.41B | 1.01B | 324.34M | 392.83M | 65.70M | 70.80M | 39.63M |
| Total Debt | 71.11M | 29.22M | 17.94M | 16.78M | 0 | 161,000 | 458,000 | 4.50M |
| Cash & Equivalents | 387.88M | 397.45M | 834.66M | 68.98M | 386.20M | 58.98M | 66.09M | 36.14M |
| Operating Cash Flow | (452.63M) | (296.79M) | (170.60M) | (121.39M) | (46.63M) | (47.15M) | (30.47M) | (14,963) |
| Free Cash Flow | (475.05M) | (364.67M) | (176.44M) | (127.95M) | (47.78M) | (48.34M) | (32.24M) | (16,185) |
| FCF per Share | -3.89 | -3.75 | -2.72 | -2.46 | -1.62 | -12.74 | -8.88 | -0.00 |
| Book Value | 3.31B | 1.24B | 953.61M | 284.02M | 345.84M | (106.37M) | (57.73M) | 30.94M |
| Cash & ST Investments | 1.75B | 1.08B | 931.38M | 245.97M | 386.20M | 58.98M | 66.09M | 36.14M |
| ROC Equity | -0.14 | -0.32 | -0.23 | -0.35 | -0.26 | N/A | N/A | -0.56 |